^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in sodium chloride 0.45%.

^d Tested in both dextrose 5% and sodium chloride 0.9%.

^e Tested in combination with heparin sodium (Riker) 1000 units/L.

^f Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.

^g Tested in combination with hydrocortisone sodium succinate (Upjohn) 100 mg/L.

^h Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

ⁱ Tested in dextrose 5% with potassium chloride 0.02 mM/mL.

^j Lyophilized formulation tested.

^k Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^l Test performed using the formulation WITHOUT edetate disodium.

^m Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

ⁿ Tested undiluted.

^o Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^p Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^q Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^r Test performed using the formulation WITH edetate disodium.

^s Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^t Tested in sterile water for injection.